Acceso abierto

Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system

M.D. Ilsley

M.D. Ilsley

Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund UniversityLund, Sweden
Buscar este autor en
Sciendo|Google Scholar
Ilsley, M.D.
, 
J.R. Storry

J.R. Storry

Experimental Transfusion Medicine, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Technical Director, Immunohematology, Department of Clinical Immunology and Transfusion Medicine, Office of Medical ServicesLund,
Buscar este autor en
Sciendo|Google Scholar
Storry, J.R.
 y 
M.L. Olsson

M.L. Olsson

Transfusion Medicine, Deputy Dean, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing, Department of Clinical Immunology and Transfusion Medicine, Office of Medical ServicesLund,
Buscar este autor en
Sciendo|Google Scholar
Olsson, M.L.
  
28 dic 2022
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Publicado en línea: 28 dic 2022
Páginas: 130 - 136
DOI: https://doi.org/10.21307/immunohematology-2022-055
Palabras clave
© 2022 M.D. Ilsley et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina de laboratorio
RSS Feed de revista